title: Lower cardiac troponin T and I results in heparin-plasma than in serum.
abstract: BACKGROUND
  The use of plasma rather than serum for determination of cardiac troponins can improve turnaround time and potentially avoid incomplete serum separation that may produce falsely increased results. We investigated the influence of incomplete serum separation and the effect of heparin-plasma on cardiac troponin concentrations.
  
  
  METHODS
  Serum and heparin-plasma samples were drawn simultaneously from 100 patients (50 patients with acute coronary syndrome and 50 patients after open heart surgery) and measured on three different analytical systems, two for determination of cardiac troponin I (cTnI; Abbott AxSYM and Bayer ACS:Centaur) and one for cardiac troponin T (cTnT; Roche Elecsys cTnT STAT). Serum samples were reanalyzed after a second centrifugation to assess the influence of incomplete serum separation.
  
  
  RESULTS
  Mean results (+/- 95% confidence interval) in heparin-plasma compared with serum were 101% +/- 2% (AxSYM cTnI), 94% +/- 3% (ACS:Centaur cTnI), and 99% +/- 3% (Elecsys cTnT). Differences >20% were seen in 11% of results on the ACS:Centaur, 9% of results on Elecsys cTnT, and 2% of results on the AxSYM. For the Elecsys cTnT assay, the magnitude of the difference between serum and plasma was independent of the absolute concentration and confined to individual samples, and was reversed by treatment with heparinase. A second centrifugation had no effect on serum results by any of the assays.
  
  
  CONCLUSIONS
  The concentrations of troponins measured in heparin-plasma are markedly lower than in serum in some cases.
authors.affiliation: Institut für Klinische Chemie und Pathobiochemie, Medizinische Klinik I, and Klinik für Thorax-, Herz- und Gefässchirurgie, Universitätsklinikum der RWTH Aachen, 52074 Aachen, Germany. hugo.stiegler@post.rwth-aachen.de
authors.forename: H
authors.initials: H
authors.lastname: Stiegler
authors.forename: Y
authors.initials: Y
authors.lastname: Fischer
authors.forename: J F
authors.initials: JF
authors.lastname: Vazquez-Jimenez
authors.forename: J
authors.initials: J
authors.lastname: Graf
authors.forename: K
authors.initials: K
authors.lastname: Filzmaier
authors.forename: B
authors.initials: B
authors.lastname: Fausten
authors.forename: U
authors.initials: U
authors.lastname: Janssens
authors.forename: A M
authors.initials: AM
authors.lastname: Gressner
authors.forename: D
authors.initials: D
authors.lastname: Kunz
mesh_terms: D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000175:diagnosis; D005189:False Positive Reactions; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D019210:Troponin I / Q000097:blood*; D020107:Troponin T / Q000097:blood*
chemical_list: D000925:Anticoagulants; D019210:Troponin I; D020107:Troponin T; D006493:Heparin